Literature DB >> 20141153

Hierarchical assembly of extended coordination networks constructed by novel metallacalix[4]arenes building blocks.

Xia Li1, Benlai Wu, Ruiying Wang, Hongyun Zhang, Caoyuan Niu, Yunyin Niu, Hongwei Hou.   

Abstract

Five interesting metal-organic nanostructures and networks, [Ni(4)(HL)(4)(bpy)(py)(H(2)O)(5)](2) x 0.5 H(2)O (1), [Co(4)(HL)(4)(bpy)(py)(H(2)O)(5)](2) x 0.5 H(2)O (2), [Ni(4)(HL)(4)(H(2)O)(7)](n) x nH(2)O (3), [Ni(4)(HL)(4)(bpy)(2)(H(2)O)(4)](n) (4), and [Cd(4)(HL)(4)(H(2)O)](n) (5), were synthesized hydrothermally [H(3)L = 2-(pyridin-2-yl)-1H-imidazole-4,5-dicarboxylate acid, py = pyridine, and bpy = 4,4'-bipyridine]. Intriguingly, all compounds consist of novel metallacalix[4]arene building blocks M(4)(HL)(4), where doubly deprotonated HL in the same bichelating fashion of mu-kN,N':kO,N'' displays a strong coordination orientation by cooperation of the 4,5-imidazoledicarboxylate and 2-pyridyl groups. Very interestingly, the symmetry of M(4)(HL)(4) and the linkage styles between metal nodes and HL in M(4)(HL)(4) are sensitive to the reaction conditions, and the resulting structural motifs vary with secondary ligands and metal nodes. In 1 and 2, two C(1)-symmetric M(4)(HL)(4) units are bpy-bridged into dimeric chiral nanomolecules with two different cavities. As deprotonated with NaOH, the combination of Ni(II) and HL forms a pseudo-S(4)- or S(4)-symmetric M(4)(HL)(4), which further assembles into 1D chiral crystals 3 or rare 3D crystals 4 of bpy-bridged 5-fold interpenetrating diamondoid architecture with metallacalix[4]arene building blocks as novel 4-connecting nodes, and the combination of Cd(II) and HL forms an 8-connected C(2)-symmetric M(4)(HL)(4) that fabricates the alpha-Po net of 5. Notably, those large M(4)(HL)(4) units are potentially highly connected building blocks in a hierarchical assembly of metal-organic networks. Magnetic studies disclose antiferromagnetic interactions in M(4)(HL)(4) of 1-4. The magnetic data for 1, 3, and 4, all containing isomeric Ni(4)(HL)(4) units, are analyzed by an equilateral quadrangle isotropic model combined with the molecular-field approximation with J = -4.00(2), -3.39(2), and -2.72(3) cm(-1), respectively, presenting a stronger comparison between the structure and magnetism. The emission of 5 is odd, which perhaps is relative to the bichelating fashion of ligand HL and a rare coordination geometry of Cd(II). Moreover, the thermal stability and gas sorption properties of these compounds were measured.

Entities:  

Year:  2010        PMID: 20141153     DOI: 10.1021/ic901113p

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  6 in total

1.  Synthesis and characterization of ultraviolet light-emitting organic acids.

Authors:  Chun-Ai An; Yanchao Guo; Zhenjun Si; Qian Duan
Journal:  J Fluoresc       Date:  2014-02-13       Impact factor: 2.217

2.  5-Carb-oxy-2-isopropyl-1H-imidazol-3-ium-4-carboxyl-ate monohydrate.

Authors:  Chao-Jun Du; Zheng-Hai Shi; Li-Sheng Wang; Chao-Ling Du
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-30

3.  catena-Poly[iron(II)-bis-{μ-5-carb-oxy-2-[(1H-1,2,4-triazol-1-yl)meth-yl]-1H-imidazole-4-carboxyl-ato}].

Authors:  Yan Tong; Hui-Jie Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-30

4.  catena-Poly[[[diaqua-[3-(pyridin-4-yl)benzoato-κ(2)O,O']gadolinium(III)]-bis-[μ-3-(pyridin-4-yl)benzoato-κ(2)O:O']] monohydrate].

Authors:  Dong-Ying Li; Guo-Ting Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-16

5.  Triaqua[2,2'-(propane-1,3-diyl)bis(5-carboxy-1H-imidazole-4-carboxylato-κ(2)N(3),O(4))]calcium(II) tetrahydrate.

Authors:  Ling-Zhi Du; Xia Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-23

6.  Aqua-[2,2'-(propane-1,3-di-yl)bis-(5-car-boxy-1H-imidazole-4-carboxyl-ato)-κ(4)N(3),O(4):N(3'),O(4')](pyridine-κN)cobalt(II)-4,4'-bipyridine (1/1).

Authors:  Wei Liu; Xia Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.